ShuYu Civilian Pharmacy Corp., Ltd. (SHE:301017)
China · Delayed Price · Currency is CNY 13.70
+0.51 (3.87%)
At close: Aug 3, 2026
SHE:301017 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 1,461 | 1,241 | 1,405 | 1,397 | 1,860 | 622.06 |
Trading Asset Securities | 1 | - | - | 100.07 | - | 121.42 |
Cash & Short-Term Investments | 1,462 | 1,241 | 1,405 | 1,498 | 1,860 | 743.47 |
Cash Growth | 5.58% | -11.69% | -6.20% | -19.50% | 150.23% | 31.79% |
Accounts Receivable | 1,122 | 1,096 | 1,313 | 1,346 | 896.39 | 462.04 |
Other Receivables | 306.26 | 313.38 | 191.04 | 49.18 | 33.84 | 44.23 |
Receivables | 1,428 | 1,410 | 1,504 | 1,395 | 930.24 | 506.27 |
Inventory | 1,961 | 1,893 | 1,891 | 2,068 | 1,794 | 1,226 |
Prepaid Expenses | - | 0.83 | 0.53 | 0.35 | - | - |
Other Current Assets | 600.04 | 475.56 | 520.91 | 549.6 | 388.23 | 254.2 |
Total Current Assets | 5,451 | 5,020 | 5,321 | 5,511 | 4,972 | 2,730 |
Property, Plant & Equipment | 1,299 | 1,327 | 1,425 | 1,427 | 1,257 | 1,025 |
Long-Term Investments | 139.39 | 206.49 | 232.3 | 225.03 | 258.25 | 225.81 |
Goodwill | 2,264 | 2,264 | 1,753 | 1,387 | 975.06 | 667.24 |
Other Intangible Assets | 144.95 | 147.75 | 130.13 | 128.18 | 111.51 | 68.92 |
Long-Term Deferred Tax Assets | 152.31 | 136.18 | 164.24 | 83.06 | 52.88 | 48.6 |
Long-Term Deferred Charges | 95.05 | 94.29 | 97.23 | 116.46 | 102.66 | 68.44 |
Other Long-Term Assets | 280.04 | 211.51 | 150.56 | 455.86 | 133.07 | 167.83 |
Total Assets | 9,827 | 9,408 | 9,273 | 9,334 | 7,863 | 5,003 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 3,381 | 3,146 | 2,510 | 1,898 | 1,777 | 1,021 |
Accrued Expenses | 100.62 | 150.26 | 139.61 | 152.73 | 159.8 | 95.75 |
Short-Term Debt | 1,090 | 869.48 | 1,685 | 1,631 | 1,210 | 550.79 |
Current Portion of Long-Term Debt | 779.23 | 428.72 | 232.24 | 144.55 | 51.77 | 10.64 |
Current Portion of Leases | - | 332.26 | 377.74 | 425.68 | 337.31 | 242.21 |
Current Income Taxes Payable | 93.31 | 54.63 | 57.44 | 33.19 | 56.42 | 20.62 |
Current Unearned Revenue | 55.73 | 65.25 | 75.98 | 91.4 | 68.57 | 27.96 |
Other Current Liabilities | 425.37 | 500.45 | 284.83 | 887.02 | 545.63 | 653.6 |
Total Current Liabilities | 5,926 | 5,547 | 5,362 | 5,264 | 4,206 | 2,623 |
Long-Term Debt | 1,229 | 1,193 | 1,341 | 1,338 | 988.28 | 162.44 |
Long-Term Leases | 337.16 | 244.68 | 342.53 | 333.91 | 374.68 | 270.16 |
Long-Term Unearned Revenue | 17.25 | 17.33 | 11.14 | 11.43 | 12.27 | 13.11 |
Long-Term Deferred Tax Liabilities | 14.45 | 14.94 | 22.88 | 19.73 | 14.47 | 10.78 |
Other Long-Term Liabilities | - | 96.7 | 68.21 | 0.75 | - | 9.26 |
Total Liabilities | 7,523 | 7,114 | 7,148 | 6,967 | 5,596 | 3,089 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 405.61 | 405.36 | 405.35 | 405.34 | 405.34 | 405.34 |
Additional Paid-In Capital | 804.46 | 800.81 | 831.55 | 831.33 | 856.99 | 857.19 |
Retained Earnings | 829.01 | 818.65 | 704.42 | 913.35 | 826.9 | 627.06 |
Treasury Stock | - | - | -42.97 | - | - | - |
Comprehensive Income & Other | 105.57 | 106.06 | 142.01 | 142.05 | 142.05 | - |
Total Common Equity | 2,145 | 2,131 | 2,040 | 2,292 | 2,231 | 1,890 |
Minority Interest | 158.4 | 162.55 | 84.7 | 74.17 | 35.79 | 24.45 |
Shareholders' Equity | 2,303 | 2,293 | 2,125 | 2,366 | 2,267 | 1,914 |
Total Liabilities & Equity | 9,827 | 9,408 | 9,273 | 9,334 | 7,863 | 5,003 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 3,435 | 3,069 | 3,978 | 3,873 | 2,962 | 1,236 |
Net Cash (Debt) | -1,973 | -1,828 | -2,573 | -2,376 | -1,102 | -492.77 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -5.09 | -4.48 | -6.41 | -5.89 | -2.74 | -1.29 |
Filing Date Shares Outstanding | 405.61 | 405.61 | 402.36 | 405.34 | 405.34 | 405.34 |
Total Common Shares Outstanding | 405.61 | 405.36 | 402.36 | 405.34 | 405.34 | 405.34 |
Working Capital | -474.42 | -527.34 | -41.32 | 246.84 | 766.05 | 107.45 |
Book Value Per Share | 5.29 | 5.00 | 4.72 | 5.30 | 5.15 | 4.66 |
Tangible Book Value | -264.75 | -281.32 | 157.73 | 776.71 | 1,145 | 1,153 |
Tangible Book Value Per Share | -0.65 | -0.96 | 0.04 | 1.57 | 2.47 | 2.85 |
Buildings | - | 725.67 | 538.31 | 415.79 | 412.23 | 369.65 |
Machinery | - | 362.94 | 301.19 | 246.47 | 201.96 | 164.94 |
Construction In Progress | - | 79.24 | 162.87 | 145.59 | 25.61 | 22.61 |